SharkNinja Inc. Ordinary Shares vs State Street SPDR S&P Biotech ETF — how do they compare? SharkNinja Inc. Ordinary Shares trades at $184.8 (market cap $26.09B), while State Street SPDR S&P Biotech ETF trades at $149.94 (market cap $10.08B). The key difference: SharkNinja Inc. Ordinary Shares is far larger — about 2.6× State Street SPDR S&P Biotech ETF's market cap, and SharkNinja Inc. Ordinary Shares is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SharkNinja Inc. Ordinary Shares for 0 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.
| SN | XBI | |
|---|---|---|
Market Cap | $26.09B | $10.08B |
Volume | 1,288,403 | 9,534,635 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $192.86 | $169.55 |
52-Week Low | $84.57 | $104.99 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $26.22B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $150.23, down 0.44% on the day, with bearish technical signals dominating. The ETF faces resistance near $152-154 while finding support at $147-149 levels. Analyst coverage remains limited with a single hold rating, though recent news highlights biotech sector optimism from M&A activity and cancer vaccine breakthroughs. The fund's 0.35% expense ratio compares unfavorably to broader healthcare ETFs but offers targeted biotech exposure.
Outlook remains mixed with technical weakness offset by sector catalysts. The biotech focus provides growth potential but carries higher volatility than diversified healthcare alternatives. Key risks include sector-specific regulatory pressures and the fund's expense structure, while opportunities exist from ongoing pharmaceutical innovation and capital market improvements.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SharkNinja designs and sells small household appliances under the Shark and Ninja brands. Its products include cleaning appliances, kitchen and beverage appliances, food preparation products, and beauty and home-environment devices.
Read more on SN →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →